|
Initial 2 of 8.Unomedical hereby submits this initial report as part of its complaint remediation activities conducted under a capa 2356421 and capa 2566479 in accordance with the fda action plan, which incorporates qp-ic-2026-0020 (ic retrospective complaint review) and qp-ic-2026-0024 (ic retrospective mdr review).This submission includes a retrospective reassessment of previously evaluated complaints.Unomedical is providing this supplemental information in accordance with the reporting requirements set forth in 21 cfr part 803.Any fields left blank indicate that the information is unknown, unavailable, or remains unchanged.Additional information - this medical device report (mdr)is being submitted to include the below:
h6: investigation results under type of investigation, investigation findings, investigation conclusions.H11: investigation summary.Complaint investigation results:
review of complaint record event description and all available information was completed and no lot number specific information identified.Requests for lot specific information were sent to the customer but were unable to be provided.As a result, an investigation was completed at the product family inset and malfunction type leakage related malfunctions.See full investigation results in documentum file (b)(4) version 1.Corrective and preventive action (capa) determination:
based on the available information, no further investigation is required nor corrective and preventive action (capa) plan is needed.The record will be closed and monitored through tracking and trending (monthly trips and alerts).Summary conclusion:
based on the available information and the investigation performed, the complaint will be closed as complaint unconfirmed due to lack of information.Based on the available information, this event is deemed to be a reportable malfunction.A complaint investigation was initiated under complaint investigation.Unfortunately, no specific lot number was identified, which limits the ability to trace or analyze a particular item.Investigation in progress.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number:
reporting site: 8021545,
manufacturing site: 3003442380.
|